Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001997535 | SCV002230293 | pathogenic | not provided | 2023-11-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg519*) in the RINT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RINT1 are known to be pathogenic (PMID: 31204009). This variant is present in population databases (rs759853907, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with RINT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1449407). For these reasons, this variant has been classified as Pathogenic. |
Ambry Genetics | RCV004043919 | SCV002708839 | uncertain significance | not specified | 2022-10-05 | criteria provided, single submitter | clinical testing | The p.R519* variant (also known as c.1555C>T), located in coding exon 11 of the RINT1 gene, results from a C to T substitution at nucleotide position 1555. This changes the amino acid from an arginine to a stop codon within coding exon 11. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. |
Neurometabolic Diseases Laboratory, |
RCV003336470 | SCV003918810 | pathogenic | RINT1-related disorder | 2023-04-20 | criteria provided, single submitter | research |